THE APOPLIPOPROTEIN E (APOE) GENOTYPE IN
A TURKISH POPULATION WITH ALZHEIMER’S DISEASE
M.B. Yoke_1, M. Emre2, H. Harmanc_3, H. Gürvit2,
H. Hana_as_2, H. _ahin2, B. Bilgiē2, A.N. Ba_ak1
*Corresponding Author: A. Nazl_ Ba_ak, PhD, Bo_aziēi University, Department of Molecular Biology and Genetics, Bebek 34342, Istanbul, Turkey; Tel.: +90-212-359-66-79; Fax: +90-212-287-24-68; E-mail: basak@ boun.edu.tr
page: 57
|
|
Abstract
Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. Three genes are known that, when mutated, cause early-onset AD: β-amyloid precursor protein (APP) gene, presenilin-1 (PS1) gene and pre-senilin-2 (PS2) gene. The majority of AD cases, however, are late-onset and sporadic, occuring in families in whom the inheritance pattern is unclear. This suggests a complex interaction of genetic and environmental factors underlying the etiology of the disease. The Apoplipoprotein E (ApoE)-E4 allele is the most common genetic determinant of susceptibility to late-onset AD (LOAD). The objective this study was to determine the frequency of the three common APOE alleles in a Turkish population with AD, in comparison with non AD elderly controls. One thousand and seventeen randomly selected individuals over the age of 70 years were screened with a validated Turkish version of the Mini Mental Status Examination (MMSE), and 281 selected subjects underwent detailed clinical examination. Of these, 57 were diagnosed as probable AD subjects and 11 as possible AD subjects. One hundred and twenty-seven subjects were considered to be cognitively normal and were used as controls. The frequencies of the E2 and E4 alleles in the Turkish population were among the lowest reported worldwide, and different from those of other Caucasian populations. Despite its overall low frequency, the E4 allele was almost twice as frequent in patients with AD, compared to controls.
Key words: Alzheimer’s disease (AD), Apoplipoprotein E (ApoE) gene, Turkey.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
